Parenteral product quality is improving. Since 2014, when USP <790> “Visible Particulates in Injections” (1) became official, particle-related recalls of injectable products have dropped significantly ...
The industry is taking steps to automate the final product inspection process for complex therapeutics. Prior to a pharmaceutical product making its way into the supply chain, companies must perform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results